Human Immunoglobulin (Ph4) For Intravenous Injection
Products
Information
The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. ?Indications? 1. Primary agammaglobulinemia, such as X-linked hypogammaglobulinemia, common variant immunodeficiency diseases, immunoglobulin G subclass deficiency, etc. 2. Secondary immunoglobulin deficiency diseases, such as severe infection, septicemia of newborn, etc 3. Autoimmune diseases, such as primary thrombocytopenic purpura, Kawasaki disease. ?Specifications? 0.5g/vial (5%, 10ml), 1 g/vial (5%, 20ml), 1.25g/vial (5%, 25ml), 2.5g/vial (5%, 50ml), 5gvial (5%, 100ml), 10g/vial (5%, 200ml).
Main Categories
BiopharmaceuticalsFinished Dosage Forms
All Categories
BiopharmaceuticalsBiopharmaceuticals (general category)Finished Dosage FormsImmunology
Distribution areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
China
